Medical Health & Life Science Research News

Detailed examination of the global injectable drug delivery market to reflect a significant CAGR +11.5% and worth $789.7 billion by 2024

Detailed examination of the global injectable drug delivery market to reflect a significant CAGR +11.5% and worth $789.7 billion by 2024

"Global Injectable Drug Delivery Market" is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

- Advertising -

"Global Injectable Drug Delivery Market" is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. 

`This Report Contains:

  • No of Pages: 868
  • No of Tables: 955
  • No of Figures: 50

Request For Free Sample Report @: databridgemarketresearch.com/reque…g-delivery-market

Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration  (Skin, Circulatory, Organs, Central Nervous System), End User  (Hospitals & Clinics, Home Care Settings, Research Laboratories,  Pharma & Biotech Companies), Geography (North America,  Europe, Asia-Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024

Injectable Drug Delivery Market – Market Segmentation:

Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.

- Advertising -

The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. In 2017, the hospital &clinics segment is expected to dominate the market and is expected to continue this trend till 2024.

Browse Full Report @ databridgemarketresearch.com/repor…-delivery-market/

Based on geography, the market is segmented into five geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.

Table Of Content :

  1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL INJECTABLEDRUG DELIVERY MARKET

1.2. CURRENCY AND PRICING

1.3. LIMITATION

1.4. MARKETS COVERED

  1. MARKET SEGMENTATION

2.1. MARKETS COVERED

2.2. GEOGRAPHIC SCOPE

2.3. YEARS CONSIDERED FOR THE STUDY

2.4. CURRENCY AND PRICING

2.5. RESEARCH METHODOLOGY

2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7. SECONDARY SOURCES

2.8. ASSUMPTIONS

  1. MARKET OVERVIEW

3.1. DRIVERS

3.2. RESTRAINTS

3.4. CHALLENGES

  1. EXECUTIVE SUMMARY
  1. PREMIUM INSIGHTS
  1. GLOBAL INJECTABLE DRUG DELIVERY MARKET, REGULATORY

6.1. OVERVIEW

  1. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE

7.1. OVERVIEW

7.2. INJECTABLE DRUG DELIVERY DEVICES

7.3. INJECTABLE DRUG DELIVERY FORMULATION

7.3.2. NOVEL DRUG DELIVERY FORMULATIONS

  1. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION

8.1. OVERVIEW

8.2. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION

8.3. HORMONAL DISORDERS

8.4. ONCOLOGY

8.5. AUTOIMMUNE DISEASES

8.6. ORPHAN DISEASE

8.7. OTHER APPLICATIONS

  1. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN

9.1. OVERVIEW

9.2. CURATIVE CARE

9.3. IMMUNIZATIONS

9.4. OTHER USAGE PATTERN

  1. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION

10.1. OVERVIEW

10.2. SKIN

10.3. CIRCULATORY/ MUSKOSKELETAL

10.4. ORGANS

10.5. CENTRAL NERVOUS SYSTEM

  1. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY END USER

11.1. OVERVIEW

11.2. HOSPITALS AND CLINICS

11.3. HOME HEALTHCARE SETTINGS

11.4. RESEARCH LABORATORIES

11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES

11.6. OTHER END USERS

  1. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

12.1. OVERVIEW

  1. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY

13.3. EUROPE INJECTABLE DRUG DELIVERY MARKET

13.4. APAC INJECTABLE DRUG DELIVERY MARKET

13.5. SOUTH AMERICA INJECTABLE DRUG DELIVERY MARKET

13.6. MEA INJECTABLE DRUG DELIVERY MARKET

  1. GLOBAL INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE

14.1. COMPANY SHARE ANALYSIS: GLOBAL

  1. COMPANY PROFILES

15.1. BECTON, DICKINSON AND COMPANY

15.2. PFIZER

15.3. BAXTER INTERNATIONAL

15.4. GERRESHEIMER AG

15.6. ALKERMES INC.

15.7. ANTARES PHARMA

15.8. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)

15.9. ELCAM MEDICAL

15.10. ELI LILLY AND COMPANY

15.11. HASELMEIER

15.12. MYLAN N.V.

15.13. NOVO NORDISK

15.14. OWEN MUMFORD LTD

15.15. SANDOZ INTERNATIONAL GMBH

15.16. SANOFI

15.17. TERUMO CORPORATION

15.18. TEVA PHARMACEUTICAL

Request for Detail [email protected] databridgemarketresearch.com/toc/?…g-delivery-market

Major Players:

Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as Gerresheimer AG, Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Bespak, Antares Pharma,Elcam Medical, Haselmeier, Mylan N.V., Novo Nordisk, Owen Mumford Ltd, Sanofi, West Pharmaceutical Services, Inc, Ypsomed Holding AG.

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...